Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Integrated human immunodeficiency virus (HIV)-sexually transmitted infections (STI) risk reduction intervention program among youths
ISRCTN ISRCTN69038234
ClinicalTrials.gov identifier
Public title Integrated human immunodeficiency virus (HIV)-sexually transmitted infections (STI) risk reduction intervention program among youths
Scientific title Human immunodeficiency virus (HIV)-sexually transmitted infections (STI) risk reduction program among undergraduate students at a Northern Nigerian University: a randomised controlled field trial
Acronym IHSRIPY
Serial number at source 001
Study hypothesis 1. The intervention group will show greater increase in human immunodeficiency virus (HIV)-related and sexually transmitted infection (STI) knowledge immediately post-intervention and during follow up assessments than the control group
2. The intervention group will report greater reduction in HIV-related and STI related risk behaviours at follow up assessments than the control group
3. The intervention group will exhibit higher increase in positive attitude scores towards HIV and STI prevention immediately post-intervention and during follow up assessments than the control group
4. The intervention group will show higher increase in positive HIV-related stigma score immediately post-intervention and during follow up assessments than the control group
Lay summary
Ethics approval 1. Malaysia: Human Research Ethics Committee, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, approved on 6th June 2008
2. Nigeria: Human Research Ethics Committee, Ahmadu Bello University Zaria approved on 14th July 2008
Study design Randomised controlled field trial
Countries of recruitment Nigeria
Disease/condition/study domain Human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), sexually transmitted infections (STI)
Participants - inclusion criteria 1. Bonafide student of Ahmadu Bello University
2. Aged less than 25 years, either sex
3. Single
4. Students willing to complete the 6-month planned follow-up assessment
Participants - exclusion criteria 1. Students with documented mental, emotional, or cognitive problem identified by self-reporting or information from the students' department
2. Students in final year of their study
Anticipated start date 01/09/2008
Anticipated end date 01/03/2009
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 240
Interventions A randomised controlled field trial design to investigate the impact of an HIV-STI intervention program on participants' HIV- and STI-related knowledge, sexual risk behaviours, attitudes towards HIV and STI prevention, and disentanglement of stigma. Participants were randomised to either the intervention group or the control group. An 8-hour integrated HIV-STI prevention program comprising of four structured modules was developed and delivered to the intervention group, while the control group received another 8-hour program on career development. Two-way repeated measure ANOVA was applied to assess the effectiveness of the intervention. The outcome measures were assessed at baseline, immediately post-intervention, at 3 months and 6 months post-intervention for both arms.

Contact details of joint sponsor:
Ahmadu Bello University, Zaria (Nigeria)
Department of Community Medicine
Faculty of Medicine
P.M.B 09, Samaru Zaria
Nigeria
Primary outcome measure(s) 1. HIV-related and STI knowledge at baseline, 3 and 6 months post-intervention
2. HIV-related and STI risk behaviours at baseline, 3 and 6 months post-intervention
3. HIV-related and STI attitude at baseline, 3 and 6 months post-intervention
4. HIV-related stigma at baseline, 3 and 6 months post-intervention
Secondary outcome measure(s) Evaluation of the effectiveness of a school-based risk-reduction intervention program on behavioural risk factors for HIV and STI. Assessed at baseline, immediate post-intervention (except sexual risk behaviors and number of partners), 3 and 6 months post-intervention.
Sources of funding 1. Investigator intiatied and funded (Nigeria)
2. Ahmadu Bello University, Zaria (Nigeria) - logistical support only
Trial website
Publications
Contact name Dr  Saad  Abdulmumin
  Address Department of Community Medicine
Faculty of Medicine
Universiti Putra Malaysia
  City/town Serdang
  Zip/Postcode 43400
  Country Malaysia
  Email elsaad99@yahoo.com
Sponsor Universiti Putra Malaysia (Malaysia)
  Address c/o Dr Saad Abdulmumin
Department of Community of Health
Faculty of Medicine
  City/town Serdang
  Zip/Postcode 43400
  Country Malaysia
  Email elsaad99@yahoo.com
  Sponsor website: http://www.upm.edu.my/
Date applied 03/02/2010
Last edited 26/02/2010
Date ISRCTN assigned 26/02/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central